Kyorin Pharmaceutical Co.,ltd. Forecast, price target & analysts
Kyorin Pharmaceutical Co.,ltd. Target price 2026 - Analyst rating & recommendation
Kyorin Pharmaceutical Co.,ltd. Classifications & Recommendation
Kyorin Pharmaceutical Co.,ltd. Price Target
| Target Price | ¥1,203.60 |
| Price | ¥1,128.00 |
| Potential |
6.70%
register free of charge
|
| Number of Estimates | 3 |
|
3 Analysts have issued a price target Kyorin Pharmaceutical Co.,ltd. 2027 .
The average Kyorin Pharmaceutical Co.,ltd. target price is ¥1,203.60.
This is
6.70%
register free of charge
¥1,323.00
17.29%
register free of charge
¥1,111.00
1.51%
register free of charge
|
|
| A rating was issued by 8 analysts: 0 Analysts recommend Kyorin Pharmaceutical Co.,ltd. to buy, 3 to hold and 5 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Kyorin Pharmaceutical Co.,ltd. stock has an average upside potential 2027 of
6.70%
register free of charge
|
Sales and Margin forecast 2027, 2028 & 2029
| Mar '26 |
2027 Estimates |
|
|---|---|---|
| Revenue Billion ¥ | 126.26 | 124.43 |
| 2.94% | 1.45% | |
| EBITDA Margin | 2.83% | 5.58% |
| 70.76% | 97.51% | |
| Net Margin | 2.73% | 1.35% |
| 60.90% | 50.57% |
3 Analysts have issued a sales forecast Kyorin Pharmaceutical Co.,ltd. 2027 . The average Kyorin Pharmaceutical Co.,ltd. sales estimate is
This results in the following potential growth metrics:
3 Analysts have issued an Kyorin Pharmaceutical Co.,ltd. EBITDA forecast 2027. The average Kyorin Pharmaceutical Co.,ltd. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
3 Kyorin Pharmaceutical Co.,ltd. Analysts have issued a net profit forecast 2027. The average Kyorin Pharmaceutical Co.,ltd. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2027, 2028 & 2029
| Mar '26 |
2027 Estimates |
|
|---|---|---|
| Earnings Per Share ¥ | 60.02 | 29.29 |
| 62.05% | 51.20% | |
| P/E | 38.51 | |
| EV/Sales | 0.53 |
3 Analysts have issued a Kyorin Pharmaceutical Co.,ltd. forecast for earnings per share. The average Kyorin Pharmaceutical Co.,ltd. EPS is
This results in the following potential growth metrics and future valuations:
Kyorin Pharmaceutical Co.,ltd....
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
